Results 141 to 150 of about 286,924 (257)

Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer. [PDF]

Sci Rep
Djusberg E, Lundquist K, Lundholm M, Josefsson A, Karlsson CT, Schwenk JM, Brattsand M, Bergh A, Wikström P.   +8 more
europepmc   +1 more source

Frequency of complex-to-manage, difficult-to-manage and treatment-refractory psoriatic arthritis: applying the 2025 GRAPPA and EULAR definitions in a real-world longitudinal PsA cohort. [PDF]

RMD Open
Koc GH, Kok MR, Snoeck Henkemans SVJ, Luime JJ, Tchetverikov I, Korswagen LA, Denissen NHAM, Goekoop-Ruiterman YPM, Baudoin P, Kok P, Bos R, Dolhain RJEM, Proft F, Vis M, CICERO.   +14 more
europepmc   +1 more source

Reevaluating PSA Testing Rates in the PLCO Trial.

New England Journal of Medicine, 2016
J. Shoag, S. Mittal, Jim C Hu
semanticscholar   +1 more source

Revealing Hidden Dynamics of Hydrogel-Based Desalination with ²³Na Nuclear Magnetic Resonance. [PDF]

J Phys Chem C Nanomater Interfaces
Zou H, Zhang C, Teleanu F, Jangizehi A, Seiffert S, Jerschow A.   +5 more
europepmc   +1 more source

Assessing flares in patients with psoriatic arthritis using questionnaires. [PDF]

RMD Open
Chronis NJ, Pereira D, Gao S, Chandran V.   +3 more
europepmc   +1 more source

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology, 2010
P. Kantoff, T. Schuetz, Brent A. Blumenstein, L. Glode, D. Bilhartz, M. Wyand, K. Manson, D. Panicali, R. Laus, J. Schlom, William L Dahut, P. Arlen, J. Gulley, W. Godfrey   +13 more
semanticscholar   +1 more source

Circulatory microRNA signature distinguishing rheumatoid arthritis and psoriatic arthritis. [PDF]

Rheumatology (Oxford)
Tynan Ó, Hanlon MM, Floudas A, Wade S, Fearon U, Veale DJ.   +5 more
europepmc   +1 more source

Analyzing Prostate-Specific Antigen (PSA) trajectories and the impact of COVID-19 on prostate cancer screening and diagnosis in Manitoba

Background: Prostate cancer is the most common cancer among Canadian men, yet PSA-based screening remains controversial due to concerns on over diagnosis. Despite this, PSA testing plays a key role in early detection and disease monitoring.
Wang, Qunfeng
core   +1 more source

Incorporating Lower Urinary Tract Symptoms to Predict the Risk of Positive Prostate Magnetic Resonance Imaging. [PDF]

Eur Urol Open Sci
Paulino Pereira LJ, van Melick HHE, Sedelaar MJPM, Blanker MH, van Leeuwen PJ, van den Bergh RCN.   +5 more
europepmc   +1 more source

Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies

Cancer Gene Therapy, 2016
M. Jazayeri, HaMeD aMaNi, A. Pourfatollah, A. Avan, G. A. Ferns, Hamidreza Pazoki-Toroudi   +5 more
semanticscholar   +1 more source